


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
ACTU
Actuate Therapeutics Inc.
$7.63
Strengths

Upgraded on attractively valued
ACTU Price Performance
$6.66 (+14.56%)
$8.24 (-7.40%)
$8.22 (-7.18%)
$8.22 (-7.18%)
ACTU has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

ACTU overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Analysts perspectives on the stock desirability, trend direction, and growth potential
Average key support and resistance price levels
Login to displayWhat is ACTU current stock price?
What are ACTU stock strengths?
What is ACTU Risk Level?
What is ACTU market cap and volume?
What is ACTU current Stock IQ?
Should I buy ACTU stock right now?
Is ACTU a Strong Buy right now?
What does a 'Strong Buy' rating mean for ACTU?
What does a 'Strong Sell' rating mean for ACTU?
What factors influence ACTU's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
ACTU
Actuate Therapeutics Inc.
Current Price
$7.63
Stock Insights
Strengths

Upgraded on attractively valued

ACTU Price Performance
$6.66 (+14.56%)
$8.24 (-7.40%)
$8.22 (-7.18%)
$8.22 (-7.18%)
ACTU Analysts Opinion
ACTU Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Analysts perspectives on the stock desirability, trend direction, and growth potential
ACTU has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

Average key support and resistance price levels
ACTU Stock IQ
ACTU Latest Analysis
How Much Upside is Left in Actuate Therapeutics Inc. (ACTU)? Wall Street Analysts Think 214.06%. The average of price targets set by Wall Street analysts indicates a potential upside of 214.1% in Actuate Therapeutics Inc. (ACTU). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.
Fri Nov 28, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ACTU Stock trends
ACTU Stock performance
ACTU Stock analysis
ACTU investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.